Nasal Therapeutic Vaccine for Treating Cervical Cancer
2025.11.13
Research
Cervical cancer, one of the most common cancers in women, is often treated with surgery, radiation, or chemotherapy, which can affect fertility and quality of life. Researchers at Chiba University have developed a new nasal therapeutic vaccine as a non-invasive treatment option. In animal studies, the vaccine produced strong and lasting immune responses against cervical tumors. If proven effective in humans, it could provide women with a safer, fertility-preserving alternative to current cancer treatments.
-
The experimental nasal vaccine developed at Chiba University stimulated strong and long-lasting immune responses in animal models, activating tumor-fighting cells in the cervix and slowing cervical tumor growth. This approach offers a promising new direction for cervical cancer treatment, moving beyond conventional therapies.